Pathophysiology of chronic kidney disease-mineral and bone disorder

被引:35
|
作者
Mac Way, Fabrice [1 ,2 ,3 ]
Lessard, Myriam [1 ,2 ,4 ]
Lafage-Proust, Marie-Helene [1 ,2 ]
机构
[1] Univ Lyon, INSERM, U1059, F-42023 St Etienne 2, France
[2] CHU St Etienne, F-42055 St Etienne 2, France
[3] Hotel Dieu Quebec, Nephrol, Quebec City, PQ G1R 2J6, Canada
[4] Hop Sacre Coeur Montreal, Ouest Montreal, PQ H4J 1C5, Canada
关键词
Parathyroid hormone; FGF23; Bone biopsy; Bone turnover; Osteomalacia; Secondary hyperparathyroidism; HYPERPLASTIC PARATHYROID-GLANDS; RENAL OSTEODYSTROPHY; CKD PATIENTS; SECONDARY HYPERPARATHYROIDISM; DEPRESSED EXPRESSION; DOWN-REGULATION; RECEPTOR; CALCIUM; FGF23; PTH;
D O I
10.1016/j.jbspin.2012.09.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) alters the metabolism of several minerals, thereby inducing bone lesions and vessel-wall calcifications that can cause functional impairments and excess mortality. The histological bone abnormalities seen in CKD, known as renal osteodystrophy, consist of alterations in the bone turnover rate, which may be increased (osteitis fibrosa [OF]) or severely decreased (adynamic bone disease [AD]); abnormal mineralization (osteomalacia [OM]), and bone loss. Secondary hyperparathyroidism is related to early phosphate accumulation (responsible for FGF23 overproduction by bone tissue), decreased calcitriol production by the kidneys, and hypocalcemia. Secondary hyperparathyroidism is associated with OF. Other factors that affect bone include acidosis, chronic inflammation, nutritional deficiencies, and iatrogenic complications. (C) 2012 Published by Elsevier Masson SAS on behalf of the Societe Francaise de Rhumatologie.
引用
收藏
页码:544 / 549
页数:6
相关论文
共 50 条
  • [31] Treatment of chronic kidney disease-mineral bone disorder and vascular complications
    Moe, Sharon M.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2006, 10 : S2 - S15
  • [32] Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorder
    Asamiya Y.
    Tsuchiya K.
    Nitta K.
    Renal Replacement Therapy, 2 (1) : 1 - 8
  • [33] Chronic kidney disease-mineral bone disorder and fractures in predialysis patients
    Fernandes, Bernardo
    Lopes, Mariana Diz
    Neto, Ricardo
    Frazao, Joao M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1105 - I1106
  • [34] OSTEOPROTEGERIN AS AN EARLY SIGN OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER
    Grskovic, Antun
    Celic, Tanja
    Spanjol, Josip
    Markic, Dean
    Devcic, Bosiljka
    Bobinac, Dragica
    Racki, Sanjin
    ACTA CLINICA CROATICA, 2023, 62 : 46 - 52
  • [35] Chronic Kidney Disease-Mineral Bone Disorder: New Understandings of an Old Disease
    Lerma, Edgar V.
    CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM, 2012, 10 (03): : 117 - 118
  • [36] Bone health in chronic kidney disease-mineral and bone disease
    Gal-Moscovici, Anca
    Sprague, Stuart M.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2007, 14 (01) : 27 - 36
  • [37] EVALUATION OF CHILDREN WITH KIDNEY TRANSPLANTATION IN TERMS OF CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER
    Alpay, Ayse
    Yildirim, Zeynep Yuruk
    Kucukgergin, Canan
    Aydin, Fatih
    Aksu, Bagdagul
    Yilmaz, Alev
    Nayir, Ahmet
    PEDIATRIC NEPHROLOGY, 2023, 38 : S112 - S113
  • [38] Relative comparison of chronic kidney disease-mineral and bone disorder rat models
    Zhang, Xiaoqiong
    Li, Ting
    Wang, Lijuan
    Li, Yanhui
    Ruan, Taoren
    Guo, Xiaohong
    Wang, Qin
    Meng, Xianli
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [39] Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder
    Fukagawa, Masafumi
    Yokoyama, Keitaro
    Koiwa, Fumihiko
    Taniguchi, Masatomo
    Shoji, Tetsuo
    Kazama, Junichiro James
    Komaba, Hirotaka
    Ando, Ryoichi
    Kakuta, Takatoshi
    Fujii, Hideki
    Nakayama, Msasaaki
    Shibagaki, Yugo
    Fukumoto, Seiji
    Fujii, Naohiko
    Hattori, Motoshi
    Ashida, Akira
    Iseki, Kunitoshi
    Shigematsu, Takashi
    Tsukamoto, Yusuke
    Tsubakihara, Yoshiharu
    Tomo, Tadashi
    Hirakata, Hideki
    Akizawa, Tadao
    THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 (03) : 247 - 288
  • [40] The current status of chronic kidney disease-mineral and bone disorder management in China
    Ya Zhan
    Xin He
    Daqing Hong
    Li Wang
    Guisen Li
    Scientific Reports, 12